Literature DB >> 21826533

Regulation of major histocompatibility complex class I molecule expression on cancer cells by amyloid precursor-like protein 2.

Haley L Peters1, Amit Tuli, Mahak Sharma, Naava Naslavsky, Steve Caplan, Richard G MacDonald, Joyce C Solheim.   

Abstract

The three members of the amyloid precursor protein family in mammals [amyloid precursor protein, amyloid precursor-like protein 1, and amyloid precursor-like protein 2 (APLP2)] have been implicated in a large array of intracellular processes, which include development, transcription, apoptosis, metabolism, and the cell cycle. A series of studies by our laboratories has demonstrated that APLP2 is highly expressed by many cancer cell lines (with the highest expression in pancreatic cancer cell lines) and that it facilitates major histocompatibility complex (MHC) class I molecule endocytosis. This review focuses on this recently revealed function of APLP2 relevant to tumor immunology: that it acts as a novel regulator of MHC class I molecule surface expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21826533      PMCID: PMC3194006          DOI: 10.1007/s12026-011-8238-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  49 in total

1.  Clustering of peptide-loaded MHC class I molecules for endoplasmic reticulum export imaged by fluorescence resonance energy transfer.

Authors:  T Pentcheva; M Edidin
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  Selective export of MHC class I molecules from the ER after their dissociation from TAP.

Authors:  E T Spiliotis; H Manley; M Osorio; M C Zúñiga; M Edidin
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

3.  Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments.

Authors:  P A Reid; C Watts
Journal:  Nature       Date:  1990-08-16       Impact factor: 49.962

4.  Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules.

Authors:  M A Vega; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein.

Authors:  Vivek Venkataramani; Christian Rossner; Lara Iffland; Stefan Schweyer; Irfan Y Tamboli; Jochen Walter; Oliver Wirths; Thomas A Bayer
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

6.  Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.

Authors:  Ken-ichi Takayama; Shuichi Tsutsumi; Takashi Suzuki; Kuniko Horie-Inoue; Kazuhiro Ikeda; Kiyofumi Kaneshiro; Tetsuya Fujimura; Jinpei Kumagai; Tomohiko Urano; Yoshiyuki Sakaki; Katsuhiko Shirahige; Hironobu Sasano; Satoru Takahashi; Tadaichi Kitamura; Yasuyoshi Ouchi; Hiroyuki Aburatani; Satoshi Inoue
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

7.  Amyloid precursor-like protein 2 increases the endocytosis, instability, and turnover of the H2-K(d) MHC class I molecule.

Authors:  Amit Tuli; Mahak Sharma; Mary M McIlhaney; James E Talmadge; Naava Naslavsky; Steve Caplan; Joyce C Solheim
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

8.  Molecular classification of cancer: unsupervised self-organizing map analysis of gene expression microarray data.

Authors:  David G Covell; Anders Wallqvist; Alfred A Rabow; Narmada Thanki
Journal:  Mol Cancer Ther       Date:  2003-03       Impact factor: 6.261

9.  The amyloid precursor-like protein 2 and the adenoviral E3/19K protein both bind to a conformational site on H-2Kd and regulate H-2Kd expression.

Authors:  Chantey R Morris; Jason L Petersen; Shanna E Vargas; Heth R Turnquist; Mary M McIlhaney; Sam D Sanderson; Joseph T Bruder; Yik Y L Yu; Hans-Gerhard Burgert; Joyce C Solheim
Journal:  J Biol Chem       Date:  2002-12-27       Impact factor: 5.157

10.  ADP-ribosylation factor 6 regulates a novel plasma membrane recycling pathway.

Authors:  H Radhakrishna; J G Donaldson
Journal:  J Cell Biol       Date:  1997-10-06       Impact factor: 10.539

View more
  6 in total

1.  Beta 2-microglobulin regulates amyloid precursor-like protein 2 expression and the migration of pancreatic cancer cells.

Authors:  Bailee H Sliker; Benjamin T Goetz; Haley L Peters; Brittany J Poelaert; Gloria E O Borgstahl; Joyce C Solheim
Journal:  Cancer Biol Ther       Date:  2019-02-27       Impact factor: 4.742

2.  Amyloid precursor-like protein 2 suppresses irradiation-induced apoptosis in Ewing sarcoma cells and is elevated in immune-evasive Ewing sarcoma cells.

Authors:  Haley L Peters; Ying Yan; Tara M Nordgren; Christine E Cutucache; Shantaram S Joshi; Joyce C Solheim
Journal:  Cancer Biol Ther       Date:  2013-06-26       Impact factor: 4.742

3.  APLP2 regulates the expression of MHC class I molecules on irradiated Ewing's sarcoma cells.

Authors:  Haley L Peters; Ying Yan; Joyce C Solheim
Journal:  Oncoimmunology       Date:  2013-10-08       Impact factor: 8.110

4.  APLP2 Modulates JNK-Dependent Cell Migration in Drosophila.

Authors:  Xingjun Wang; Xiaowei Guo; Yeqing Ma; Chenxi Wu; Wenzhe Li; Lei Xue
Journal:  Biomed Res Int       Date:  2018-07-29       Impact factor: 3.411

Review 5.  Amyloid precursor protein and amyloid precursor-like protein 2 in cancer.

Authors:  Poomy Pandey; Bailee Sliker; Haley L Peters; Amit Tuli; Jonathan Herskovitz; Kaitlin Smits; Abhilasha Purohit; Rakesh K Singh; Jixin Dong; Surinder K Batra; Donald W Coulter; Joyce C Solheim
Journal:  Oncotarget       Date:  2016-04-12

6.  Genomic analysis of head and neck cancer cases from two high incidence regions.

Authors:  Sandra Perdomo; Devasena Anantharaman; Matthieu Foll; Behnoush Abedi-Ardekani; Geoffroy Durand; Luciana Albina Reis Rosa; Reetta Holmila; Florence Le Calvez-Kelm; Eloiza H Tajara; Victor Wünsch-Filho; José Eduardo Levi; Marta Vilensky; Jerry Polesel; Ivana Holcatova; Lorenzo Simonato; Cristina Canova; Pagona Lagiou; James D McKay; Paul Brennan
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.